Literature DB >> 18077564

Metabolic syndrome in drug abuse.

Ashraf Virmani1, Zbigniew K Binienda, Syed F Ali, Franco Gaetani.   

Abstract

Drug abuse is associated with significant health risk. Whether drug abusers are at a higher risk of suffering the metabolic syndrome is not widely known. The metabolic syndrome is a cluster of metabolic abnormalities, including hyperinsulinemia, hypertension, dyslipidemia, and abdominal obesity, and is probably triggered by initial imbalances at the cellular level in various critical metabolic pathways. These initially small metabolic imbalances are believed to cascade with time and lead to larger problems. Some indications that drug abuse may increase the risk of the metabolic syndrome include the following: Drug-abusing patients have higher rates of diabetes complications. Substance abuse is a significant contributing factor for treatment noncompliance in diabetes. Nutrition education can enhance substance abuse treatment outcomes. Each type of drug/substance abuse has a unique profile of toxicity. For example, the amphetamines generally affect the cardiovascular and neurological systems, worsening the risk factors for the metabolic syndrome. Methamphetamine (meth) abusers suffer cognitive deficits and abnormal metabolic activity, which affect nutritional status. This condition is further worsened by a drastic reduction in oral health in meth abusers, resulting in improper chewing and, therefore, digestion. Nutritional deficiency in combination with drug abuse would increase the risk of developing the metabolic syndrome by increasing cell damage, augmenting excitotoxicity, reducing energy production, and lowering the antioxidant potential of the cells. Another potential risk factor in the development of the metabolic syndrome is genetic vulnerability, especially in combination with drug abuse and nutritional deficiencies. The strategies available to treat this problem include pharmacological agents as well as dietary antioxidants. Such measures may be useful in reducing drug abuse-related toxicity that may lead to the metabolic syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 18077564     DOI: 10.1196/annals.1403.004

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

1.  Novel multifunctional pharmacology of lobinaline, the major alkaloid from Lobelia cardinalis.

Authors:  Dustin P Brown; Dennis T Rogers; Francois Pomerleau; Kirin B Siripurapu; Manish Kulshrestha; Greg A Gerhardt; John M Littleton
Journal:  Fitoterapia       Date:  2016-04-20       Impact factor: 2.882

2.  Peripheral blood microRNA levels in females with cocaine use disorder.

Authors:  Thiago Wendt Viola; Bernardo Aguzzoli Heberle; Aline Zaparte; Breno Sanvicente-Vieira; Leonardo Mendes Wainer; Gabriel Rodrigo Fries; Consuelo Walss-Bass; Rodrigo Grassi-Oliveira
Journal:  J Psychiatr Res       Date:  2019-04-02       Impact factor: 4.791

3.  Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records.

Authors:  Yiheng Pan; Rong Xu
Journal:  BMC Med Inform Decis Mak       Date:  2022-06-16       Impact factor: 3.298

4.  Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.

Authors:  Cindy Bednasz; Amneris E Luque; Barry S Zingman; Margaret A Fischl; Barbara M Gripshover; Charles S Venuto; Jie Gu; Zekun Feng; Robin DiFrancesco; Gene D Morse; Qing Ma
Journal:  Curr Vasc Pharmacol       Date:  2016       Impact factor: 2.719

Review 5.  Emerging issues for our nation's health: the intersection of marijuana use and cardiometabolic disease risk.

Authors:  Denise C Vidot; Guillermo Prado; WayWay M Hlaing; Kristopher L Arheart; Sarah E Messiah
Journal:  J Addict Dis       Date:  2014

6.  Illicit drug use and cardiometabolic disease risk: an analysis of 2005-2008 National Health and Nutrition Examination Survey data.

Authors:  D C Vidot; K L Arheart; G Prado; E S Bandstra; S E Messiah
Journal:  Int J Clin Pract       Date:  2013-11       Impact factor: 2.503

7.  Metabolic syndrome among substance dependent men: A study from north India.

Authors:  Surendra Kumar Mattoo; Naresh Nebhinani; Munish Aggarwal; Debasish Basu; Parmanand Kulhara
Journal:  Ind Psychiatry J       Date:  2013-01

8.  The levels of triglyceride and total cholesterol in methamphetamine dependence.

Authors:  Meijuan Zhang; Dezhao Lv; Wu Zhou; Lili Ji; Beibei Zhou; Han Chen; Yingying Gu; Jiyun Zhao; Jincai He
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

9.  Evaluation of Antioxidant Status, High Sensitivity C-reactive Protein, and Insulin Resistance in Male Chronic Opiate Users Without Comorbidities.

Authors:  Purvi Purohit; Naresh Nebhinani; Praveen Sharma
Journal:  Indian J Psychol Med       Date:  2017 May-Jun

Review 10.  Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects.

Authors:  Spyridon Siafis; Dimitrios Tzachanis; Myrto Samara; Georgios Papazisis
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.